Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - CEN BIOTECH INC | ex31-1.htm |
| 10-Q - FORM 10-Q - CEN BIOTECH INC | cenb20170331_10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CEN Biotech, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bill Chaaban, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
1. |
The Report fully complies with requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: May 19, 2017
By: /s/Bill Chaaban
Bill Chaaban
Chief Executive and Chief Financial Officer